How Multiply Labs benefits their customers

Customers evaluate the quality of Multiply Labs’s products using the following success metrics.

improved production throughput / speed
labor cost reduction
operating cost reduction

Multiply Labs’s Partnerships

Partnership Start Date

5/5/2022

Thermo Fisher Scientific provides a broad range of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics applications. Clients include pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies. The company's portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, fine and high-purity chemistry production, cell culture, RNA interference analysis, and immunodiagnostic testing. show less

XX

Subscribe to see More

Partnership Start Date

Subscribe to see more

Subscribe to see more

XX

Subscribe to see More

Partnership Start Date

Subscribe to see more

Subscribe to see more

Work for Multiply Labs?

Compete with Multiply Labs?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

Work for Multiply Labs?

Compete with Multiply Labs?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

You May Also Like

O
Ori Biotech

Ori Biotech develops a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing, allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial scale manufacturing.

C
Cellares

Cellares is a cell therapy manufacturing technology startup in South San Francisco. Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies to make them more affordable and widely available to patients in need. With Cellares' proprietary platform, The Cell Shuttle, biopharma companies, academic research centers and CDMOs will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale.

Cellino Logo
Cellino

Cellino is developing an intracellular delivery technique for gene editing applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.